Trial Profile
An Early Phase 2 Study to Explore the Efficacy and Safety of JTZ-951 in Renal Anemic Patients Receiving Maintenance Hemodialysis <Anemia Correction study>
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Jan 2022
Price :
$35
*
At a glance
- Drugs Enarodustat (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Sponsors Japan Tobacco
- 01 Mar 2016 New trial record